Literature DB >> 18779722

Risk factors for posterior cystoid retinal degeneration in central serous chorioretinopathy.

Felice Cardillo Piccolino1, Roberta Rigault De La Longrais, Marilisa Manea, Simonetta Cicinelli, Giambattista Ravera.   

Abstract

PURPOSE: To identify factors associated with the development of posterior cystoid retinal degeneration (PCRD) in central serous chorioretinopathy (CSC).
METHODS: The authors retrospectively studied 51 eyes of 51 patients with chronic CSC and subretinal or intraretinal exudation documented by optical coherence tomography (OCT), and evaluated the association of hypertension, systemic use of corticosteroids, duration of symptoms, subretinal fibrosis, and large laser scars with the development of PCRD.
RESULTS: Twenty-four eyes (47%) had PCRD and 27 eyes (53%) had serous macular detachment without cystoid retinal changes. Multivariate analysis showed that a duration of symptoms exceeding 5 years (odds ratio [OR], 25.4; 95% confidence interval [CI], 2.8-233.2; P = 0.004) and subretinal fibrosis (OR, 19.1; 95% CI, 1.8-205.1; P = 0.015) were significantly associated with PCRD.
CONCLUSION: Disease duration longer than 5 years and subretinal fibrosis are associated with the development of PCRD in CSC. Prospective evaluations could substantiate the associations found in this study and further clarify their significance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18779722     DOI: 10.1097/IAE.0b013e318175421f

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  4 in total

1.  Corticosteroids usage and central serous chorioretinopathy: a meta-analysis.

Authors:  Ge Ge; Yun Zhang; Yichi Zhang; Zhihui Xu; Meixia Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-16       Impact factor: 3.117

2.  Photodynamic therapy as a treatment option for peripapillary pachychoroid syndrome: a pilot study.

Authors:  Claudio Iovino; Enrico Peiretti; Filippo Tatti; Giuseppe Querques; Enrico Borrelli; Riccardo Sacconi; Jay Chhablani; Hitesh Agrawal; Camiel J F Boon; Elon H C van Dijk; Gilda Cennamo; Marco Lupidi; Alessio Muzi; Valentina Di Iorio; Matias Iglicki; Lital Smadar; Anat Loewenstein; Dinah Zur
Journal:  Eye (Lond)       Date:  2021-04-06       Impact factor: 3.775

Review 3.  The Role of Imaging in Planning Treatment for Central Serous Chorioretinopathy.

Authors:  Stefano Da Pozzo; Pierluigi Iacono; Alessandro Arrigo; Maurizio Battaglia Parodi
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-29

Review 4.  Central serous chorioretinopathy: Current update on pathophysiology and multimodal imaging.

Authors:  George Joseph Manayath; Ratnesh Ranjan; Vanee Sheth Shah; Smita S Karandikar; Veerappan R Saravanan; Venkatapathy Narendran
Journal:  Oman J Ophthalmol       Date:  2018 May-Aug
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.